Seelos Therapeutics, Inc. (SEELQ) — Cash Flow Quality Index

Latest as of June 2024: -0.57x

Seelos Therapeutics, Inc. (SEELQ) has a Cash Flow Quality Index of -0.57x as of June 2024. Operating cash flow of $-972.00K is below net income of $1.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SEELQ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.57x

Operating CF / Net Income

Operating Cash Flow

$-972.00K

USD

Net Income

$1.71 Million

USD

Data as of

Jun 2024

Most recent filing

Annual Cash Flow Quality Index for Seelos Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Seelos Therapeutics, Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.